Blood glucose response
Evidence is limited for bitter melon and blood glucose despite a long history of use. Systematic reviewers concluded there is insufficient evidence to support it, and comparison trials found it less effective than metformin.
What may be going on: Contains compounds with insulin-like and AMPK-activating activity in laboratory models.
Not enough evidence. Not enough human research to say anything useful yet.
View the 2 sources
- Momordica charantia for type 2 diabetes mellitus.(opens in a new tab)
Systematic review · The Cochrane database of systematic reviews · 2012 · PMID 22895968
- Momordica charantia for type 2 diabetes mellitus.(opens in a new tab)
Systematic review · The Cochrane database of systematic reviews · 2010 · PMID 20166099
Deep research mode adds each paper’s own conclusion and stated limitations.